Author:
Brouwer E,Havenga M J,Ophorst O,de Leeuw B,Gijsbers L,Gillissen G,Hoeben R C,ter Horst M,Nanda D,Dirven C,Avezaat C J,Goudsmit J,Sillevis Smitt P
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference41 articles.
1. Surawicz TS, Davis F, Freels S, Laws Jr ER, Menck HR . Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 1998; 40: 151–160.
2. Miller CR, Williams CR, Buchsbaum DJ, Gillespie GY . Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas. Cancer Res 2002; 62: 773–780.
3. Vincent AJ, Esandi MC, Avezaat CJ, Vecht CJ, Sillevis Smitt P, van Bekkum DW et al. Preclinical testing of recombinant adenoviral herpes simplex virus thymidine kinase gene therapy for central nervous system malignancies. Neurosurgery 1997; 41: 442–451.
4. Immonen A, Vapalahti M, Tyynela K, Hurskainen H, Sandmair A, Vanninen R et al. AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther 2004; 10: 967–972.
5. Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S et al. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol 2003; 21: 2508–2518.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献